Table of Contents Author Guidelines Submit a Manuscript
Dermatology Research and Practice
Volume 2009 (2009), Article ID 479183, 8 pages
http://dx.doi.org/10.1155/2009/479183
Research Article

Clinical Characteristics of Cutaneous Melanoma and Second Primary Malignancies in a Dutch Hospital-Based Cohort of Cutaneous Melanoma Patients

1Department of Dermatology, Radboud University Nijmegen Medical Centre, P.O. Box 9101, 6500 HB Nijmegen, The Netherlands
2Department of Pathology, Radboud University Nijmegen Medical Centre, P.O. Box 9101, 6500 HB Nijmegen, The Netherlands

Received 19 December 2008; Revised 22 June 2009; Accepted 18 October 2009

Academic Editor: Robert Baran

Copyright © 2009 Haike M. J. van der Velden et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. E. de Vries, L. V. van de Poll-Franse, W. J. Louwman, F. R. de Gruijl, and J. W. W. Coebergh, “Predictions of skin cancer incidence in The Netherlands up to 2015,” British Journal of Dermatology, vol. 152, no. 3, pp. 481–488, 2005. View at Publisher · View at Google Scholar · View at Scopus
  2. E. de Vries, F. I. Bray, J. W. W. Coebergh, and D. M. Parkin, “Changing epidemiology of malignant cutaneous melanoma in Europe 1953–1997: rising trends in incidence and mortality but recent stabilizations in western Europe and decreases in Scandinavia,” International Journal of Cancer, vol. 107, no. 1, pp. 119–126, 2003. View at Publisher · View at Google Scholar · View at Scopus
  3. A. Jemal, S. S. Devesa, P. Hartge, and M. A. Tucker, “Recent trends in cutaneous melanoma incidence among whites in the United States,” Journal of the National Cancer Institute, vol. 93, no. 9, pp. 678–683, 2001. View at Google Scholar · View at Scopus
  4. R. M. MacKie, C. A. Bray, D. J. Hole et al., “Incidence of and survival from malignant melanoma in Scotland: an epidemiological study,” The Lancet, vol. 360, no. 9333, pp. 587–591, 2002. View at Publisher · View at Google Scholar · View at Scopus
  5. L. D. Marrett, H. L. Nguyen, and B. K. Armstrong, “Trends in the incidence of cutaneous malignant melanoma in New South Wales, 1983–1996,” International Journal of Cancer, vol. 92, no. 3, pp. 457–462, 2001. View at Publisher · View at Google Scholar · View at Scopus
  6. F. Levi, V. C. Te, L. Randimbison, G. Erler, and C. La Vecchia, “Trends in skin cancer incidence in Vaud: an update, 1976–1998,” European Journal of Cancer Prevention, vol. 10, no. 4, pp. 371–373, 2001. View at Publisher · View at Google Scholar · View at Scopus
  7. A. Stang, K. Stang, C. Stegmaier, T. Hakulinen, and K.-H. Jöckel, “Skin melanoma in saarland: incidence, survival and mortality 1970–1996,” European Journal of Cancer Prevention, vol. 10, no. 5, pp. 407–415, 2001. View at Publisher · View at Google Scholar · View at Scopus
  8. R. Ocaña-Riola, C. Martínez-García, S. Serrano, A. Buendía-Eisman, C. Ruíz-Baena, and J. Canela-Soler, “Population-based study of cutaneous malignant melanoma in the Granada province (Spain), 1985–1992,” European Journal of Epidemiology, vol. 17, no. 2, pp. 169–174, 2001. View at Publisher · View at Google Scholar · View at Scopus
  9. S. Siesling, O. Visser, J. A. A. M. van Dijck, and J. W. W. Coebergh, “Trends in the incidence and death from cancer from 1989–2003 in The Netherlands,” Nederlands Tijdschrift voor Geneeskunde, vol. 150, no. 45, pp. 2490–2496, 2006. View at Google Scholar · View at Scopus
  10. P. G. Buettner, U. Leiter, T. K. Eigentler, and C. Garbe, “Development of prognostic factors and survival in cutaneous melanoma over 25 years: an analysis of the Central Malignant Melanoma Registry of the German Dermatological Society,” Cancer, vol. 103, no. 3, pp. 616–624, 2005. View at Publisher · View at Google Scholar · View at Scopus
  11. C. Garbe, G. R. C. McLeod, and P. G. Buettner, “Time trends of cutaneous melanoma in Queensland, Australia and Central Europe,” Cancer, vol. 89, no. 6, pp. 1269–1278, 2000. View at Publisher · View at Google Scholar · View at Scopus
  12. S. Bhatia, L. Estrada-Batres, T. Maryon, M. Bogue, and D. Chu, “Second primary tumors in patients with cutaneous malignant melanoma,” Cancer, vol. 86, no. 10, pp. 2014–2020, 1999. View at Publisher · View at Google Scholar · View at Scopus
  13. L. A. DiFronzo, L. A. Wanek, R. Elashoff, and D. L. Morton, “Increased incidence of second primary melanoma in patients with a previous cutaneous melanoma,” Annals of Surgical Oncology, vol. 6, no. 7, pp. 705–711, 1999. View at Google Scholar · View at Scopus
  14. F. Levi, C. La Vecchia, L. Randimbison, V.-C. Te, and G. Erler, “Incidence of invasive cancers following cutaneous malignant melanoma,” International Journal of Cancer, vol. 72, no. 5, pp. 776–779, 1997. View at Publisher · View at Google Scholar · View at Scopus
  15. D. Nashan, B. Kocer, M. Schiller, T. Luger, and S. Grabbe, “Significant risk of a second melanoma in patients with a history of melanoma but no further predisposing factors,” Dermatology, vol. 206, no. 2, pp. 76–77, 2003. View at Publisher · View at Google Scholar · View at Scopus
  16. M.-H. Schmid-Wendtner, J. Baumert, C.-M. Wendtner, G. Plewig, and M. Volkenandt, “Risk of second primary malignancies in patients with cutaneous melanoma,” British Journal of Dermatology, vol. 145, no. 6, pp. 981–985, 2001. View at Publisher · View at Google Scholar · View at Scopus
  17. C. Wassberg, M. Thorn, J. Yuen, T. Hakulinen, and U. Ringborg, “Cancer risk in patients with earlier diagnosis of cutaneous melanoma in situ,” International Journal of Cancer, vol. 83, no. 3, pp. 314–317, 1999. View at Publisher · View at Google Scholar · View at Scopus
  18. C. Wassberg, M. Thorn, J. Yuen, U. Ringborg, and T. Hakulinen, “Second primary cancers in patients with cutaneous malignant melanoma: a population-based study in Sweden,” British Journal of Cancer, vol. 73, no. 2, pp. 255–259, 1996. View at Google Scholar · View at Scopus
  19. E. Crocetti and P. Carli, “Risk of second primary cancers, other than melanoma, in an Italian population-based cohort of cutaneous malignant melanoma patients,” European Journal of Cancer Prevention, vol. 13, no. 1, pp. 33–37, 2004. View at Publisher · View at Google Scholar · View at Scopus
  20. G. Kroumpouzos, M. M. Konstadoulakis, H. Cabral, and C. P. Karakousis, “Risk of basal cell and squamous cell carcinoma in persons with prior cutaneous melanoma,” Dermatologic Surgery, vol. 26, no. 6, pp. 547–550, 2000. View at Publisher · View at Google Scholar · View at Scopus
  21. A. J. Swerdlow, H. H. Storm, and P. D. Sasieni, “Risks of second primary malignancy in patients with cutaneous and ocular melanoma in Denmark, 1943–1989,” International Journal of Cancer, vol. 61, no. 6, pp. 773–779, 1995. View at Publisher · View at Google Scholar · View at Scopus
  22. W. B. Goggins, D. M. Finkelstein, and H. Tsao, “Evidence for an association between cutaneous melanoma and non-Hodgkin lymphoma,” Cancer, vol. 91, no. 4, pp. 874–880, 2001. View at Publisher · View at Google Scholar · View at Scopus
  23. D. B. McKenna, D. Stockton, D. H. Brewster, and V. R. Doherty, “Evidence for an association between cutaneous malignant melanoma and lymphoid malignancy: a population-based retrospective cohort study in Scotland,” British Journal of Cancer, vol. 88, no. 1, pp. 74–78, 2003. View at Publisher · View at Google Scholar · View at Scopus
  24. M. Gutman, A. Cnaan, M. Inbar et al., “Are malignant melanoma patients at higher risk for a second cancer?” Cancer, vol. 68, no. 3, pp. 660–665, 1991. View at Google Scholar · View at Scopus
  25. T. Tihan and D. A. Filippa, “Coexistence of renal cell carcinoma and malignant lymphoma: a causal relationship or coincidental occurrence?” Cancer, vol. 77, no. 11, pp. 2325–2331, 1996. View at Publisher · View at Google Scholar · View at Scopus
  26. L. B. Travis, R. E. Curtis, H. Storm et al., “Risk of second malignant neoplasms among long-term survivors of testicular cancer,” Journal of the National Cancer Institute, vol. 89, no. 19, pp. 1429–1439, 1997. View at Google Scholar · View at Scopus
  27. M. H. Greene, W. H. Clark Jr., M. A. Tucker et al., “Precursor naevi in cutaneous malignant melanoma: a proposed nomenclature,” The Lancet, vol. 2, no. 8202, p. 1024, 1980. View at Google Scholar · View at Scopus
  28. International Agency for Research on Cancer, “International rules for multiple primary cancers (ICD-0 Third Edition),” 2004, http://www.iacr.com.fr/MPrules_july2004.pdf.
  29. A. Breslow, “Thickness, cross-sectional areas and depth of invasion in the prognosis of cutaneous melanoma,” Annals of Surgery, vol. 172, no. 5, pp. 902–908, 1970. View at Google Scholar · View at Scopus
  30. W. H. Clark Jr., L. From, E. A. Bernardino, and M. C. Mihm, “The histogenesis and biologic behavior of primary human malignant melanomas of the skin,” Cancer Research, vol. 29, no. 3, pp. 705–727, 1969. View at Google Scholar · View at Scopus
  31. C. M. Balch, A. C. Buzaid, S.-J. Soong et al., “Final version of the American Joint Committee on Cancer staging system for cutaneous melanoma,” Journal of Clinical Oncology, vol. 19, no. 16, pp. 3635–3648, 2001. View at Google Scholar · View at Scopus
  32. C. M. Balch, S.-J. Soong, J. E. Gershenwald et al., “Prognostic factors analysis of 17,600 melanoma patients: validation of the American Joint Committee on Cancer melanoma staging system,” Journal of Clinical Oncology, vol. 19, no. 16, pp. 3622–3634, 2001. View at Google Scholar · View at Scopus
  33. A. Katalinic, U. Kunze, and T. Schafer, “Epidemiology of cutaneous melanoma and non-melanoma skin cancer in Schleswig-Holstein, Germany: incidence, clinical subtypes, tumour stages and localization (epidemiology of skin cancer),” British Journal of Dermatology, vol. 149, no. 6, pp. 1200–1206, 2003. View at Publisher · View at Google Scholar · View at Scopus
  34. E. Cho, B. A. Rosner, and G. A. Colditz, “Risk factors for melanoma by body for whites,” Cancer Epidemiology Biomarkers and Prevention, vol. 14, no. 5, pp. 1241–1244, 2005. View at Publisher · View at Google Scholar · View at Scopus
  35. J. M. Elwood and R. P. Gallagher, “Body site distribution of cutaneous malignant melanoma in relationship to patterns of sun exposure,” International Journal of Cancer, vol. 78, no. 3, pp. 276–280, 1998. View at Publisher · View at Google Scholar · View at Scopus
  36. L. N. Clark, D. B. Shin, A. B. Troxel, S. Khan, A. J. Sober, and M. E. Ming, “Association between the anatomic distribution of melanoma and sex,” Journal of the American Academy of Dermatology, vol. 56, no. 5, pp. 768–773, 2007. View at Publisher · View at Google Scholar · View at Scopus
  37. C. Bevona, W. Goggins, T. Quinn, J. Fullerton, H. Tsao, and R. Corona, “Cutaneous melanomas associated with nevi,” Archives of Dermatology, vol. 139, no. 12, pp. 1620–1624, 2003. View at Publisher · View at Google Scholar · View at Scopus
  38. E. Cho, B. A. Rosner, D. Feskanich, and G. A. Colditz, “Risk factors and individual probabilities of melanoma for whites,” Journal of Clinical Oncology, vol. 23, no. 12, pp. 2669–2675, 2005. View at Publisher · View at Google Scholar · View at Scopus
  39. S. Gandini, F. Sera, M. S. Cattaruzza et al., “Meta-analysis of risk factors for cutaneous melanoma: III. Family history, actinic damage and phenotypic factors,” European Journal of Cancer, vol. 41, no. 14, pp. 2040–2059, 2005. View at Publisher · View at Google Scholar · View at Scopus
  40. D. Ford, J. M. Bliss, A. J. Swerdlow et al., “Risk of cutaneous melanoma associated with a family history of the disease,” International Journal of Cancer, vol. 62, no. 4, pp. 377–381, 1995. View at Publisher · View at Google Scholar · View at Scopus
  41. M. A. Tucker, M. C. Fraser, A. M. Goldstein, D. E. Elder, D.-P. Guerry IV, and S. M. Organic, “Risk of melanoma and other cancers in melanoma-prone families,” Journal of Investigative Dermatology, vol. 100, no. 3, pp. 350S–355S, 1993. View at Google Scholar · View at Scopus
  42. S. N. Markovic, L. A. Erickson, R. D. Rao et al., “Malignant melanoma in the 21st century, part 1: epidemiology, risk factors, screening, prevention, and diagnosis,” Mayo Clinic Proceedings, vol. 82, no. 3, pp. 364–380, 2007. View at Publisher · View at Google Scholar · View at Scopus
  43. W. Bergman, P. Watson, J. de Jong, H. T. Lynch, and R. M. Fusaro, “Systemic cancer and the FAMMM syndrome,” British Journal of Cancer, vol. 61, no. 6, pp. 932–936, 1990. View at Google Scholar · View at Scopus
  44. E. Azizi, J. Friedman, F. Pavlotsky et al., “Familial cutaneous malignant melanoma and tumors of the nervous system: a hereditary cancer syndrome,” Cancer, vol. 76, no. 9, pp. 1571–1578, 1995. View at Publisher · View at Google Scholar · View at Scopus
  45. A. Borg, T. Sandberg, K. Nilsson et al., “High frequency of multiple melanomas and breast and pancreas carcinomas in CDKN2A mutation-positive melanoma families,” Journal of the National Cancer Institute, vol. 92, no. 15, pp. 1260–1266, 2000. View at Google Scholar · View at Scopus
  46. H. F. A. Vasen, N. A. Gruis, R. R. Frants, P. A. van der Velden, E. T. M. Hille, and W. Bergman, “Risk of developing pancreatic cancer in families with familial atypical multiple mole melanoma associated with a specific 19 deletion of p16 (p16-Leiden),” International Journal of Cancer, vol. 87, no. 6, pp. 809–811, 2000. View at Publisher · View at Google Scholar · View at Scopus
  47. W. H. de vos tot Nederveen Cappel, G. J. A. Offerhaus, M. van Puijenbroek et al., “Pancreatic carcinoma in carriers of a specific 19 base pair deletion of CDKN2A/p16 (p16-Leiden),” Clinical Cancer Research, vol. 9, no. 10, pp. 3598–3605, 2003. View at Google Scholar · View at Scopus
  48. A. M. Goldstein, M. C. Fraser, J. P. Struewing et al., “Increased risk of pancreatic cancer in melanoma-prone kindreds with p16(INK4) mutations,” The New England Journal of Medicine, vol. 333, no. 15, pp. 970–974, 1995. View at Publisher · View at Google Scholar · View at Scopus
  49. A. J. Whelan, D. Bartsch, and P. J. Goodfellow, “Brief report: a familial syndrome of pancreatic cancer and melanoma with a mutation in the CDKN2 tumor-suppressor gene,” The New England Journal of Medicine, vol. 333, no. 15, pp. 975–977, 1995. View at Publisher · View at Google Scholar · View at Scopus
  50. M. H. Skolnick and L. A. Cannon-Albright, “Genetic predispositions to breast cancer,” Cancer, vol. 70, supplement 4, pp. 1747–1754, 1992. View at Google Scholar · View at Scopus
  51. F. H. Menko, M. A. Nooy, and H. F. A. Vasen, “Hereditary mutations in the p53 tumor suppressor gene: the significance for clinical practice. National Work Group Hereditary Mamma Carcinoma,” Nederlands Tijdschrift voor Geneeskunde, vol. 140, no. 26, pp. 1347–1350, 1996. View at Google Scholar · View at Scopus
  52. J. Wolff and U. Wollina, “Second malignancies in melanoma patients in Thuringia,” Journal of the European Academy of Dermatology and Venereology, vol. 14, no. 6, pp. 479–483, 2000. View at Publisher · View at Google Scholar · View at Scopus
  53. L. Titus-Ernstoff, A. E. Perry, S. K. Spencer et al., “Multiple primary melanoma: two-year results from a population-based study,” Archives of Dermatology, vol. 142, no. 4, pp. 433–438, 2006. View at Publisher · View at Google Scholar · View at Scopus
  54. P. Savoia, P. Quaglino, A. Verrone, and M. G. Bernengo, “Multiple primary melanomas: analysis of 49 cases,” Melanoma Research, vol. 8, no. 4, pp. 361–366, 1998. View at Publisher · View at Google Scholar · View at Scopus
  55. S. Kang, R. L. Barnhill, M. C. Mihm Jr., and A. J. Sober, “Multiple primary cutaneous melanomas,” Cancer, vol. 70, no. 7, pp. 1911–1916, 1992. View at Google Scholar · View at Scopus
  56. T. L. Diepgen and V. Mahler, “The epidemiology of skin cancer,” British Journal of Dermatology, vol. 146, supplement 61, pp. 1–6, 2002. View at Google Scholar · View at Scopus
  57. E. de Vries, M. Louwman, M. Bastiaens, F. de Gruijl, and J. W. Coebergh, “Rapid and continuous increases in incidence rates of basal cell carcinoma in the southeast Netherlands since 1973,” Journal of Investigative Dermatology, vol. 123, no. 4, pp. 634–638, 2004. View at Publisher · View at Google Scholar · View at Scopus
  58. S. Franceschi, F. Levi, L. Randimbison, and C. La Vecchia, “Site distribution of different types of skin cancer: new aetiological clues,” International Journal of Cancer, vol. 67, no. 1, pp. 24–28, 1996. View at Publisher · View at Google Scholar · View at Scopus
  59. S. Rosso, R. Zanetti, M. Pippione, and H. Sancho-Garnier, “Parallel risk assessment of melanoma and basal cell carcinoma: skin characteristics and sun exposure,” Melanoma Research, vol. 8, no. 6, pp. 573–583, 1998. View at Google Scholar · View at Scopus
  60. R. Zanetti, S. Rosso, C. Martinez et al., “Comparison of risk patterns in carcinoma and melanoma of the skin in men: a multi-centre case-case-control study,” British Journal of Cancer, vol. 94, no. 5, pp. 743–751, 2006. View at Publisher · View at Google Scholar · View at Scopus
  61. C. Kennedy, C. D. Bajdik, R. Willemze, F. R. de Gruijl, and J. N. Bouwes Bavinck, “The influence of painful sunburns and lifetime sun exposure on the risk of actinic keratoses, seborrheic warts, melanocytic nevi, atypical nevi, and skin cancer,” Journal of Investigative Dermatology, vol. 120, no. 6, pp. 1087–1093, 2003. View at Publisher · View at Google Scholar · View at Scopus